Cubist Systematic Strategies, LLC Voyager Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $675,303 - $1.02 Million	94,448 New	94,448 $879,000
Q2 2023 Aug 14, 2023	SELL	$6.94 - $13.99 $536,628 - $1.08 Million	-77,324 Reduced 80.83%	18,335 $209,000
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $573,954 - $1.03 Million	95,659 New	95,659 $737,000
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $149,560 - $200,576	-26,851 Reduced 42.93%	35,693 $211,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $730,904 - $1.53 Million	-151,640 Reduced 70.8%	62,544 $370,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $532,567 - $1.83 Million	193,661 Added 943.63%	214,184 $1.63 Million
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $50,691 - $113,902	20,523 New	20,523 $56,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $101,155 - $139,666	-25,674 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $118,357 - $232,092	25,674 New	25,674 $121,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $175,485 - $241,051	-17,531 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $200,702 - $354,283	-24,932 Reduced 58.71%	17,531 $221,000
Q1 2020 May 15, 2020	SELL	$6.8 - $14.66 $152,789 - $329,395	-22,469 Reduced 34.6%	42,463 $389,000
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $173,864 - $228,519	13,562 Added 26.4%	64,932 $906,000
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $837,844 - $1.45 Million	51,370 New	51,370 $884,000
Q1 2019 May 15, 2019	SELL	$8.0 - $19.66 $354,312 - $870,721	-44,289 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $380,442 - $799,416	44,289 New	44,289 $416,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $267,771 - $340,231	-15,650 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $43,391 - $61,928	-2,589 Reduced 14.19%	15,650 $306,000
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $294,742 - $571,063	18,239 New	18,239 $343,000

Others Institutions Holding VYGR

# of Institutions

128

Shares Held

36.7M

Call Options Held

48K

Put Options Held

36.2K

Black Rock Inc. New York, NY

5.31M
Shares

$31.1 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.4 Million
0.54% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.9 Million
1.1% of portfolio
Vanguard Group Inc Valley Forge, PA

3.04M
Shares

$17.8 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.4 Million
0.09% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account